{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:38:23Z","timestamp":1762508303551,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.oooo.2020.10.005","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T01:27:52Z","timestamp":1602811672000},"page":"e157-e162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Osteonecrosis of the jaw associated with imatinib therapy in myeloproliferative neoplasm: a rare case report"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7812-2118","authenticated-orcid":false,"given":"Lokendra","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchan","family":"Dholam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh","family":"Janghel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep V.","family":"Gurav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5 Suppl","key":"10.1016\/j.oooo.2020.10.005_bib0001","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0002","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-015-3335-3","article-title":"Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015","volume":"27","author":"Khan","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.oooo.2020.10.005_bib0003","doi-asserted-by":"crossref","first-page":"1115\u20101117","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0004","doi-asserted-by":"crossref","first-page":"283\u2010284","DOI":"10.1080\/08869634.2016.1211812","article-title":"Goodbye BRONJ\u2026 hello MRONJ","volume":"34","author":"Weeda","year":"2016","journal-title":"Cranio"},{"key":"10.1016\/j.oooo.2020.10.005_bib0005","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0006","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/dj4040032","article-title":"Prevalence of medication-related osteonecrosis of the jaw in patients with breast cancer, prostate cancer, and multiple myeloma","volume":"4","author":"Rugani","year":"2016","journal-title":"Dent J (Basel)"},{"key":"10.1016\/j.oooo.2020.10.005_bib0007","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/odi.12708","article-title":"Risk factors for medication-related osteonecrosis of the jaws: a systematic review","volume":"24","author":"McGowan","year":"2017","journal-title":"Oral Dis"},{"key":"10.1016\/j.oooo.2020.10.005_bib0008","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.oooo.2018.09.008","article-title":"Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment","volume":"127","author":"Nicolatou-Galitis","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0009","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jcms.2016.09.018","article-title":"Clinical features of peri-implant medication-related osteonecrosis of the jaw: is there an association to peri-implantitis?","volume":"44","author":"Troeltzsch","year":"2016","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0010","first-page":"869","article-title":"Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors","volume":"26","author":"van Cann","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.oooo.2020.10.005_bib0011","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.job.2019.03.005","article-title":"Medication-related osteonecrosis of the jaw: a literature review","volume":"61","author":"Kuroshima","year":"2019","journal-title":"J Oral Biosci"},{"key":"10.1016\/j.oooo.2020.10.005_bib0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2231-0762.178742","article-title":"Medication-related osteonecrosis of the jaw: clinical and practical guidelines","volume":"6","author":"Rosella","year":"2016","journal-title":"J Int Soc Prev Community Dent"},{"key":"10.1016\/j.oooo.2020.10.005_bib0013","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/gm206","article-title":"The pharmacogenetics of imatinib","volume":"2","author":"Dulucq","year":"2010","journal-title":"Genome Med"},{"key":"10.1016\/j.oooo.2020.10.005_bib0014","doi-asserted-by":"crossref","first-page":"120\u2010124","DOI":"10.5125\/jkaoms.2017.43.2.120","article-title":"A rare case of osteonecrosis of the jaw related to imatinib","volume":"43","author":"Viviano","year":"2017","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3816\/CGC.2007.n.030","article-title":"Treatment of advanced renal cell carcinoma with the combination bevacizumab\/erlotinib\/imatinib: a phase I\/II trial","volume":"5","author":"Hainsworth","year":"2007","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.oooo.2020.10.005_bib0016","first-page":"169","article-title":"FIP1 L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia","volume":"67","author":"Cools","year":"2005","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0017","first-page":"1","article-title":"FIP1 L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia","volume":"9","author":"Loules","year":"2009","journal-title":"BMC Blood Disord"},{"key":"10.1016\/j.oooo.2020.10.005_bib0018","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0019","first-page":"904","article-title":"Efficacy and safety of oxum in treatment of chronic wounds","volume":"107","author":"Abhyankar","year":"2009","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.oooo.2020.10.005_bib0020","article-title":"Efficacy and safety of oxum in treatment of the venous ulcer","volume":"106","author":"Dharap","year":"2008","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/j.oooo.2020.10.005_bib0021","first-page":"384","article-title":"Health technology assessment on super oxidized water for treatment of chronic wounds","volume":"30","author":"Eftekharizadeh","year":"2016","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.oooo.2020.10.005_bib0022","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.oooo.2016.06.019","article-title":"Pentoxifylline and tocopherol in the management of cancer patients with medication-related osteonecrosis of the jaw: an observational retrospective study of initial case series","volume":"122","author":"Owosho","year":"2016","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0023","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1200\/JCO.19.01186","article-title":"Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO clinical practice guideline","volume":"37","author":"Yarom","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0024","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4317\/medoral.18076","article-title":"Bisphosphonate-related osteonecrosis of the jaws (BRONJ)","volume":"18","author":"Beninati","year":"2013","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.oooo.2020.10.005_bib0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2014.07.012","article-title":"Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: a pooled case report analysis","volume":"73","author":"Hinson","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0026","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review","volume":"44","author":"Fliefel","year":"2015","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0027","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx R","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0028","doi-asserted-by":"crossref","first-page":"268\u2010275","DOI":"10.1016\/j.oooo.2017.11.022","article-title":"Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics","volume":"125","author":"De Bruyn","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0029","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tripleo.2011.08.024","article-title":"Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications","volume":"113","author":"Nicolatou-Galitis","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0030","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","article-title":"Sunitinib related osteonecrosis of jaw: a case report","volume":"113","author":"Fleissig","year":"2012","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0031","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00238-015-1112-3","article-title":"Sunitinib related osteonecrosis of the jaw (SURONJ): a rare occurrence","volume":"39","author":"Melloni","year":"2016","journal-title":"Eur J Plastic Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8071579","article-title":"Osteonecrosis of the jaw associated with antiangiogenics in antiresorptive-na\u00efve patient: a comprehensive review of the literature","volume":"2018","author":"Pimolbutr","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.oooo.2020.10.005_bib0033","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/adj.12254","article-title":"Osteonecrosis of the jaw in a patient receiving cabozantinib","volume":"60","author":"Marino","year":"2015","journal-title":"Australian Dent J"},{"issue":"Suppl 2","key":"10.1016\/j.oooo.2020.10.005_bib0034","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.5301\/tj.5000504","article-title":"Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinoma","volume":"102","author":"Garuti","year":"2016","journal-title":"Tumori"},{"key":"10.1016\/j.oooo.2020.10.005_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.oooo.2017.10.010","article-title":"Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort","volume":"125","author":"Abel Mahedi Mohamed","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0036","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2006-10-050054","article-title":"Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1 L1-PDGFRA-positive chronic eosinophilic leukemia","volume":"109","author":"Jovanovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2020.10.005_bib0037","first-page":"29","article-title":"Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib. A case report with clinical implications","volume":"4","author":"Nicolatou-Galitis","year":"2013","journal-title":"Forum Clin Oncol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0038","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1200\/JCO.2012.45.1294","article-title":"Osteonecrosis of the tibia associated with imatinib in metastatic GI stromal tumor","volume":"31","author":"Yeh","year":"2013","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.oooo.2020.10.005_bib0039","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood-2009-08-237404","article-title":"Dysregulation of bone remodeling by imatinib mesylate","volume":"115","author":"Vandyke","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.oooo.2020.10.005_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131192","article-title":"Impact of long-term exposure to the tyrosine kinase inhibitor imatinib on the skeleton of growing rats","volume":"10","author":"Tauer","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.oooo.2020.10.005_bib0041","first-page":"2102\u20102108","article-title":"Imatinib mesylate and nilotinib decrease synthesis of bone matrix in vitro","volume":"18","author":"Kroschwald","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.oooo.2020.10.005_bib0042","doi-asserted-by":"crossref","first-page":"8570","DOI":"10.1200\/JCO.2005.02.4729","article-title":"Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis","volume":"23","author":"Delanian","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0043","doi-asserted-by":"crossref","first-page":"114\u2010123","DOI":"10.1002\/hed.20121","article-title":"Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial","volume":"27","author":"Delanian","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.oooo.2020.10.005_bib0044","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bjoms.2008.04.006","article-title":"Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment","volume":"46","author":"Lyons","year":"2008","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0045","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2020.10.005_bib0046","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.joms.2013.06.188","article-title":"Pentoxifylline and tocopherol in the treatment of yearly zoledronic acid-related osteonecrosis of the jaw in a corticosteroid-induced osteoporosis","volume":"72","author":"Magremanne","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.oooo.2019.08.004","article-title":"Systematic review of the use of pentoxifylline and tocopherol for the treatment of medication-related osteonecrosis of the jaw","volume":"128","author":"Heifetz-Li","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.10.005_bib0048","first-page":"e788","article-title":"The assessment of surgical and non-surgical treatment of stage II medication-related osteonecrosis of the jaw","volume":"22","author":"Eguchi","year":"2017","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.oooo.2020.10.005_bib0049","doi-asserted-by":"crossref","first-page":"738\u2010748","DOI":"10.1016\/j.joms.2019.12.008","article-title":"The effect of platelet-rich fibrin membrane in surgical therapy of medication-related osteonecrosis of the jaw","volume":"78","author":"Szentpeteri","year":"2020","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/ors.12318","article-title":"The role of piezoelectric surgery and platelet\u2010rich fibrin in treatment of ORN and MRONJ: a clinical case series","volume":"11","author":"Bilimoria","year":"2018","journal-title":"Oral Surg"},{"key":"10.1016\/j.oooo.2020.10.005_bib0051","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2684924","article-title":"The dental management of patients at risk of medication-related osteonecrosis of the jaw. new paradigm of primary prevention","volume":"2018","author":"Di Fede","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.oooo.2020.10.005_bib0052","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00198-017-4063-7","article-title":"A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ","volume":"28","author":"Hasegawa","year":"2017","journal-title":"Osteoporos Int"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440320312724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440320312724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:08:09Z","timestamp":1761948489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440320312724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2212440320312724"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2020.10.005","relation":{},"ISSN":["2212-4403"],"issn-type":[{"type":"print","value":"2212-4403"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteonecrosis of the jaw associated with imatinib therapy in myeloproliferative neoplasm: a rare case report","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2020.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}